According to the latest reports, Apple Watch Series 6 is a reliable way to monitor blood oxygen saturation in patients with lung diseases, which may help future medical treatments. Apple Watch Series 6 introduces a blood oxygen sensor on wearable devices, which allows users to learn more about their overall health. In a study, Apple’s sensors may have some important medical applications.
The study by the University of São Paulo in Brazil was published in Nature and was discovered by the 9to5Mac website. The study compared Apple Watch Series 6 with a pair of commercial pulse oximeters. Approximately 100 patients with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) from a lung disease clinic were analyzed by the device.
There is a strong positive correlation between Apple Watch and commercial oximeters used to assess heart rate and blood oxygen measurement. Although the blood oxygen measurement data of the Apple Watch is high on average, the study did not observe significant differences in blood oxygen and heart rate data.
The study concluded: Our results show that Apple Watch 6 is a reliable way to obtain the heart rate and arterial oxygen saturation of patients with lung diseases under controlled conditions. With the continuous improvement of smartwatch technology, research should be carried out. Assess the accuracy and reliability of various types of diseases.
In fact, Apple itself is also cooperating with external organizations to carry out its own research in various medical fields. In April of this year, Apple collaborated with the University of Washington and the Seattle Flu Research Center to study whether Apple Watch can predict diseases, such as Volt’s syndrome or other respiratory diseases.
In September of this year, Eiogen, Apple, and the University of California, Los Angeles started a study on how the Apple Watch detects neurological diseases, including symptoms of dementia and depression.
